Kidney Cancer Clinical Trial

Advanced Diffusion Imaging in Renal Cancer Patients

Summary

The objective of this study is to apply advanced diffusion imaging in a two-pronged assessment of renal mass patients: (1) characterization of lesion malignancy and subtype, and (2) prediction of renal function stability or decline following partial nephrectomy.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Renal mass patients scheduled for laparoscopic partial nephrectomy.
eGFR above 30 ml/min/m2.
Ages 21 to 85
Must be willing and able to provide consent.

Exclusion Criteria:

All metal implants and dental implants that have ferromagnetic properties and are unsafe at 3.0 T.
Pregnant women are not eligible for participating in this study.
Acute claustrophobia

Study is for people with:

Kidney Cancer

Estimated Enrollment:

150

Study ID:

NCT06116253

Recruitment Status:

Recruiting

Sponsor:

NYU Langone Health

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

NYU Langone Health
New York New York, 10016, United States More Info
Malika Kumbella
Contact
646-501-0075
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

150

Study ID:

NCT06116253

Recruitment Status:

Recruiting

Sponsor:


NYU Langone Health

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.